Cargando…
Advances in spinal muscular atrophy therapeutics
Spinal muscular atrophy (SMA) is a progressive, recessively inherited neuromuscular disease, characterized by the degeneration of lower motor neurons in the spinal cord and brainstem, which leads to weakness and muscle atrophy. SMA currently represents the most common genetic cause of infant death....
Autores principales: | Parente, Valeria, Corti, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802612/ https://www.ncbi.nlm.nih.gov/pubmed/29434670 http://dx.doi.org/10.1177/1756285618754501 |
Ejemplares similares
-
Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1
por: Vanoli, Fiammetta, et al.
Publicado: (2015) -
Identification of Novel Biomarkers of Spinal Muscular Atrophy and Therapeutic Response by Proteomic and Metabolomic Profiling of Human Biological Fluid Samples
por: Meneri, Megi, et al.
Publicado: (2023) -
miRNA in spinal muscular atrophy pathogenesis and therapy
por: Magri, Francesca, et al.
Publicado: (2017) -
Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA)
por: Zanetta, Chiara, et al.
Publicado: (2014) -
Spinal muscular atrophy with respiratory distress type 1: Clinical phenotypes, molecular pathogenesis and therapeutic insights
por: Saladini, Matteo, et al.
Publicado: (2019)